Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product
Aug 21 2023
•
By
Brenda Sandburg
FDA is asked to order recall of unapproved phenobarbital sodium products • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership